Safety and Pharmacokinetic Characterization of Nacubactam, a Novel beta-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers-论文-万方医学网

首页> > Safety and Pharmacokinetic Characterization of Nacubactam, a Novel beta-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

Safety and Pharmacokinetic Characterization of Nacubactam, a Novel beta-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

导出原文传递

翻译打印收藏纠错

第一作者： Mallalieu, Navita L.

作者： Mallalieu, Navita L. ^[1] ; Winter, Erica ^[2] ; Fettner, Scott ^[3] ; Patel, Katie ^[4] ; Zwanziger, Elke ^[5] ; Attley, Gemma ; Rodriguez, Ignacio ; Kano, Akiko ; Salama, Sameeh M. ; Bentley, Darren ; Geretti, Anna Maria

作者单位： Roche Innovat Ctr, New York, NY USA ^[1] Roche Innovat Ctr, Welwyn Garden City, England ^[2] Roche Innovat Ctr, Basel, Switzerland ^[3] Meiji Seika Pharma Co Ltd, Tokyo, Japan ^[4] Fedora Pharmaceut Inc, Edmonton, AB, Canada ^[5]

关键词 beta-lactam beta-lactamase inhibitor meropenem multiple ascending dose nacubactam pharmacokinetics phase I single ascending dose

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Safety and Pharmacokinetic Characterization of Nacubactam, a Novel beta-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

相似文献

同项目论文

相关期刊

检索历史 清除

Safety and Pharmacokinetic Characterization of Nacubactam, a Novel beta-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

相似文献

同项目论文

相关期刊

检索历史清除